Amphetamine-Related Disorders and Medical Marijuana

71 minute read
0
(0)

Short answer

Amphetamine use disorder is a pattern of using amphetamine or methamphetamine that keeps causing harm, and it is treated with therapy and support. No study in people has tested medical cannabis as a treatment for it. What exists are animal experiments and surveys that show links, not causes, and cannabis can become a second dependence of its own. Any form of cannabis, smoked, eaten or taken under the tongue, is a question for a physician first.

This guide draws on 10 published studies, each marked by who was studied: people, animals or survey answers. The full picture starts at what the research shows.

Overdose, psychosis or thoughts of suicide: when to get help right now

High doses of amphetamine or methamphetamine can overload the heart, the brain and the body’s temperature control within hours. The days after a binge bring their own danger, when exhaustion and a low mood can turn into thoughts of ending your life. If any sign below fits you or someone near you, get help first. Questions about cannabis can wait.

  • Chest pain or pressure, a racing or skipping heartbeat, or fainting.
  • Very hot skin, confusion or no sweat in the heat: the body is overheating.
  • A seizure, a sudden severe headache, weakness on one side or slurred speech.
  • Hearing or seeing things that are not there, or a strong fear that people are out to get you.
  • Thoughts of suicide or of hurting someone, often during the crash after heavy use.

Help-line details as published by the 988 Suicide and Crisis Lifeline [1] and SAMHSA [2].

What to tell the responders

  1. What was taken, how much and when, including THC, alcohol and anything bought on the street.
  2. Every prescription, especially a stimulant for ADHD, an antidepressant or an antipsychotic.
  3. Whether the person has had psychosis, a heart problem or a seizure before.

Responders are there to treat, and what you tell them changes which tests they run and which medicines they choose.

If you are worried about someone you love How the disorder is treated

How this guide was put together

  • Each research figure carries a numbered source, and the full list sits at the foot of the page.
  • Every study is labeled by who took part: people, rodents, or survey answers.
  • A link between two habits is called a link, never proof that one causes the other.
  • The medical content was reviewed by the Dr. Weedy medical team, physicians with state licenses. See who they are.

Crash, cravings, sleepless nights and shame: what stimulant problems take from daily life

It rarely starts as a problem. A pill that helped with a double shift, a line that made a party easier, a prescription that worked and then needed a little more. Then the rhythm sets in: days of energy and focus, a crash into sleep and gloom, and a pull to use again just to feel normal.

Over months, that cycle wears down sleep, appetite, money, work and the people around you. Many people also carry a quieter weight: the fear that a doctor will hear the word methamphetamine and stop listening.

The crash after the high

Exhaustion, long sleep, hunger and a flat or hopeless mood follow heavy use. Craving is strongest in exactly this stretch.

Withdrawal and the crash

A body running on alarm

A fast heart, high blood pressure, weight loss, clenched teeth and nights without sleep add up long before anyone calls it a disorder.

Effects on the body and mind

Fear of being judged

Physicians see stimulant problems every week. Saying plainly what you use is what lets them keep you safe.

How to talk to a physician

Treatment exists, recovery is common, and it starts with an honest conversation. The sections below explain the disorder first, then what is and is not known about cannabis.

Cutting down, in treatment, on a prescription, or reading for someone you love: where to start

Tap the situation closest to yours to see the parts of this guide written for it. Tap it again to see all five.

You want to cut down or stop

Behavioral therapy has the strongest record for stimulant problems, and several medicines are being studied. Cannabis is not a tested way to quit, and it can become a second habit.

How it is treated Cannabis in recovery

You are in a treatment program, drug court or on probation

A medical card does not override the conditions you agreed to. A positive THC test can still count against you, so ask your counselor, officer or attorney before anything changes.

Drug tests, programs and privacy

You take a prescribed stimulant for ADHD or narcolepsy

Taking it as directed is not a use disorder, and tolerance under a doctor’s care does not count toward one. Adding THC raises heart rate further and can unsettle sleep and anxiety.

What counts toward the diagnosis Interactions

You already use cannabis

The main questions are a second dependence, psychosis and your heart. A physician who knows your stimulant history can weigh them for you.

Safety and who should avoid it Forms of cannabis

Someone close to you is using

Calm, specific conversations work better than confrontation. Keep the crisis numbers at hand and learn the warning signs.

How to help Warning signs

Amphetamine use disorder is a pattern of using amphetamine, methamphetamine or a related stimulant that leads to real harm or distress, shown by at least 2 of 11 signs within the same 12 months. Its formal name in the DSM-5-TR, the diagnostic manual used by US clinicians, is stimulant use disorder, amphetamine-type substance [3]. Older texts call it amphetamine abuse or amphetamine dependence; the current manual folded both into one diagnosis graded mild, moderate or severe.

The same manual groups every stimulant problem under one heading, so amphetamine and cocaine share the 11 criteria and differ in the substance and the codes.

Amphetamine-type stimulant use disorder

Substances

Amphetamine, dextroamphetamine, lisdexamfetamine, methamphetamine, used outside a prescription or beyond it.

ICD-10-CM codes

F15.10 for mild, F15.20 for moderate or severe [4].

Cocaine use disorder

Substances

Powder cocaine and crack, a shorter-acting stimulant with a different supply and pattern of use.

ICD-10-CM codes

F14.10 for mild, F14.20 for moderate or severe [4].

The amphetamine-related disorders family

“Amphetamine-related disorders” is the umbrella for every diagnosis a stimulant can cause, not only the use disorder [3].

Use disorder the pattern

The repeated pattern of use with loss of control and harm, graded by how many of the 11 criteria apply.

Intoxication hours

The state right after use: a fast heart, wide pupils, sweating or chills, restlessness, talkativeness, sometimes nausea, confusion or a dangerous rise in temperature.

Withdrawal days to weeks

What follows stopping after heavy use: a low mood plus fatigue, vivid dreams, too much or too little sleep, hunger and slowed or agitated movement.

Stimulant-induced psychotic disorder serious

Paranoia, hallucinations or fixed false beliefs caused by the drug. It often settles once use stops, but it needs medical care, and THC can make psychotic symptoms worse.

Other stimulant-induced disorders mood, sleep, memory

Anxiety, depression, bipolar-type mood swings, sleep disorders, sexual problems and problems with memory and thinking that are caused by the stimulant rather than by an independent illness.

Unspecified amphetamine-related disorder F15.99

Used when a stimulant clearly causes trouble but the picture does not fit any of the named diagnoses, or there is not enough information yet to choose one.

ICD-10-CM codes for amphetamine-related disorders

Medical records, insurance claims and treatment referrals use these codes. Moderate and severe use disorder share one code, F15.20, so the severity is written in words next to it [4].

Filter the table by the part of the record you are trying to read.

ICD-10-CM codes for amphetamine-type substance disorders, as listed in the DSM-5-TR [3]
CodeWhat it means
F15.10Amphetamine-type use disorder, mild (2 or 3 criteria)
F15.11Mild use disorder, in early or sustained remission
F15.20Use disorder, moderate (4 or 5 criteria) or severe (6 or more): one code for both
F15.21Moderate or severe use disorder, in early or sustained remission
F15.129, F15.229, F15.929Intoxication, with mild, moderate or severe, or no use disorder
F15.122, F15.222, F15.922Intoxication with perceptual disturbances, in the same three groups
F15.13, F15.23, F15.93Withdrawal, with mild, moderate or severe, or no use disorder
F15.159, F15.259, F15.959Stimulant-induced psychotic disorder, in the same three groups
F15.99Unspecified amphetamine-related disorder

What counts as an amphetamine The 11 criteria

What counts as an amphetamine? Prescription medicines, methamphetamine and look-alikes

Amphetamines are a family of stimulants that push the brain to release dopamine and norepinephrine, the chemical messengers of alertness and reward. The common ones are prescription medicines for attention deficit hyperactivity disorder (ADHD) and narcolepsy, and methamphetamine, which is almost always made and sold illegally [6][7].

Filter by where the substance comes from.

Common amphetamines and related stimulants in the US [6][7]
SubstanceBrand or street nameWhat it is used for
Mixed amphetamine saltsAdderall, Adderall XR, MydayisADHD, narcolepsy
DextroamphetamineDexedrine, Zenzedi, ProCentraADHD, narcolepsy
LisdexamfetamineVyvanseADHD, binge eating disorder; the body turns it into dextroamphetamine
Amphetamine sulfateEvekeoADHD, narcolepsy
MethamphetamineDesoxyn by prescription, rarely; illegally “meth,” “crystal,” “ice”Rare prescription for ADHD; most supply is illegal
Diverted pills“Addys,” counterfeit pressed pillsNonmedical use; counterfeits may contain methamphetamine or fentanyl
MethylphenidateRitalin, ConcertaADHD; a stimulant, but not an amphetamine
MDMA“Ecstasy,” “molly”Built on the amphetamine structure; diagnosed with hallucinogens, not stimulants
Phentermine and similar appetite suppressantsAdipex-P, LomairaShort-term weight loss; chemically related
Synthetic cathinones“Bath salts,” “flakka”No medical use; stimulants with a similar effect
Are amphetamines narcotics? Is amphetamine a C2?

In medicine, “narcotic” means opioids such as morphine, and amphetamines are not opioids. Under federal law, amphetamine, dextroamphetamine, lisdexamfetamine and methamphetamine are Schedule II controlled substances, often written C-II: they have accepted medical uses and a high potential for misuse, so prescriptions cannot be refilled without a new order [6]. Some state laws and police reports still use “narcotic” loosely for any controlled drug.

D-amphetamine vs l-amphetamine

Amphetamine comes in two mirror-image forms. Dextroamphetamine (d-) acts more strongly on the brain; levoamphetamine (l-) has relatively more effect on the body, such as heart rate. Dexedrine and Vyvanse deliver only the d-form, Evekeo has equal parts of both, and Adderall mixes them, with more of the d-form.

Is amphetamine a Class B drug?

“Class B” is the United Kingdom’s classification, where amphetamine is Class B and methamphetamine Class A. The US uses federal schedules instead, and both are Schedule II here [6].

Can amphetamines be prescribed?

Amphetamine products are prescribed every day for ADHD and narcolepsy, with regular follow-up. Taking a prescription as directed is not a use disorder; taking more than prescribed, taking someone else’s pills or crushing and snorting them is nonmedical use.

Symptoms and the 11 criteria Stimulants and cannabis together

Amphetamine use disorder symptoms: the 11 DSM-5 criteria and mild, moderate or severe

Clinicians diagnose amphetamine use disorder by counting how many of 11 criteria have applied during the past 12 months. Two or three make it mild, four or five moderate, six or more severe [3]. The count describes how far the pattern reaches into life; it does not measure willpower.

How many criteria set the severity

How to read it: each cell is one criterion counted in the past 12 months. One alone is below the line for a diagnosis; the brackets under the cells show where mild, moderate and severe begin.

Losing control

  1. Taking more, or for longer, than you meant to.
  2. Wanting to cut down, or trying, without managing it.
  3. Spending much of your time getting, using or recovering.
  4. Craving: a strong urge or desire to use.

Life arranged around it

  1. Falling behind at work, school or home.
  2. Going on despite arguments and trouble with people close to you.
  3. Giving up activities, friends or hobbies that mattered.

Risky use

  1. Using where it is physically dangerous, such as driving.
  2. Going on while knowing it worsens a physical or mental health problem.

The body adapting

  1. Tolerance: needing more for the same effect.
  2. Withdrawal: the crash or low when you stop, or using to avoid it.

Common signs in adults

  • Long stretches without sleep, then sleeping for a day or more.
  • Weight loss, skipped meals, a dry mouth and grinding teeth.
  • Fast talk, restlessness, picking at the skin.
  • Irritability, anxiety or suspicion that is new for the person.
  • Money, pills or prescriptions that disappear faster than expected.

Withdrawal: the crash and what comes after

  1. The crash

    In the first hours to days after heavy use: deep exhaustion, long sleep, hunger and a heavy, low mood.

  2. Acute withdrawal

    In the days that follow: vivid unpleasant dreams, poor or excessive sleep, slowed thinking and strong craving.

  3. The weeks after

    Flat mood, little pleasure in usual things and waves of craving, often set off by people, places or objects tied to past use.

Only a clinician can make the diagnosis, and severe low mood or thoughts of suicide during withdrawal are a reason to call 988 now.

Check how your situation fits Warning signs

With a stimulant history, is medical cannabis worth raising for you?

Thirteen short questions about your stimulant use, your health, your medicines and the symptom you want help with. You get a summary of how your answers fit what is known and what to take to a physician. Your answers stay in this browser.

14 questions · about a minute · your answers stay in this browser

Question 1 of 14

Right now, do you have chest pain, very hot skin with confusion, hallucinations, or thoughts of suicide?

These can be signs of an emergency and need help today: 911 or 988.

Short- and long-term effects of amphetamine on the body and mind

The effects depend most on the dose and the pattern. A steady prescribed dose with medical follow-up is a different exposure from binges, smoking or injecting methamphetamine, or crushing pills, so the two are shown separately [7].

Prescribed doses, with follow-up

Short term · body

Less appetite, dry mouth, a faster pulse and slightly higher blood pressure, trouble falling asleep if taken late.

Short term · mind

Better focus for people with ADHD; for some, edginess, irritability or a low patch as the dose wears off.

Long term · body

Weight and, in children, growth are checked; heart rate and blood pressure are measured at visits.

Long term · mind

Mood and sleep are reviewed. New suspicion or hallucinations are rare and need a call to the prescriber the same day.

Nonmedical use, binges, methamphetamine

Short term · body

Racing heart, high blood pressure, overheating, jaw clenching, wide pupils; at high doses chest pain, irregular rhythm, stroke or seizure.

Short term · mind

Euphoria and energy, then agitation, anxiety, aggression, paranoia; days without sleep can trigger psychosis.

Long term · body

Weight loss, severe tooth decay (“meth mouth”), skin sores, heart muscle damage, infections from shared needles or pipes.

Long term · mind

Anxiety, depression, memory and attention problems, lasting craving, and psychosis that can return with stress or new use.

The health problems of methamphetamine come with the drug itself and with how it is taken. Smoking and injecting reach the brain fastest, which is part of why they lead to a use disorder more quickly [7].

How it is treated Signs that need help now

How is amphetamine use disorder treated? Therapy, medicines under study and where to find care

No medicine is approved by the FDA for amphetamine or methamphetamine use disorder, so care rests on behavioral therapy, treatment of whatever else is going on, and steady support [7]. People do recover, and many need more than one attempt.

  1. Treat what is urgent

    Psychosis, heart symptoms, suicidal thoughts and severe withdrawal come first, sometimes in a hospital.

  2. Behavioral therapy

    Cognitive behavioral therapy (CBT) teaches you to spot and handle triggers; contingency management rewards negative drug tests with small prizes or vouchers.

  3. Medicines under study

    Bupropion with naltrexone, and mirtazapine, have been tested in trials and are sometimes used off label; ask whether either fits you.

  4. Support that lasts

    Treatment of depression, ADHD or sleep problems, peer groups, and help with housing, work or legal trouble.

What one trial of an online program found

Finding care

FindTreatment.gov, run by SAMHSA, lists licensed programs by ZIP code, payment and type of care [10]. The SAMHSA National Helpline at 1-800-662-4357 gives free, confidential referrals at any hour [2]. Your primary care doctor can also start the conversation and refer you on.

Where cannabis fits, if at all Help for families

Cannabis in recovery from amphetamine use: help, harm, or neither?

Nobody has tested cannabis in people as a way to stop or cut down amphetamine use. The only direct signal is from rodents, given a single cannabis terpene rather than cannabis [11]. In surveys, cannabis and amphetamines tend to show up in the same lives, which says nothing about one treating the other [12].

Cannabis also carries its own risk of dependence, and people who already have one substance use disorder are more exposed to a second. Where medical cannabis can be a fair topic is the rest of your health: sleep that will not settle, anxiety, or long-standing pain, discussed with a physician who knows your stimulant history.

Not a treatment

Quitting or cutting down amphetamine

No study supports using cannabis for this, and replacing one drug with another is not a plan a physician can sign off on.

A question to bring

Symptoms that stay

Insomnia, anxiety or chronic pain that continue in stable recovery can be weighed by a physician who has your full history.

Not now

During a crisis

Psychosis, the first days of withdrawal, or suicidal thoughts are a time for urgent care, not for anything new.

An online evaluation looks at your situation rather than the diagnosis in general: the physician reviews your records, current medicines and state rules, and may decide that cannabis is not right for you.

Why researchers study cannabinoids in stimulant addiction: dopamine, CB1 and CB2

Amphetamines flood the brain’s reward circuit with dopamine, which is what makes the drug feel urgent to repeat. That circuit is wired together with the endocannabinoid system: the body’s own cannabis-like messengers and the receptors they act on, CB1 and CB2. Researchers ask whether nudging those receptors could dampen the pull of the drug. A longer explainer is on the endocannabinoid system.

Dopamine and reward

Amphetamines enter nerve endings through the dopamine transporter and push stored dopamine out through a second protein, VMAT2. The result is a surge far above anything natural rewards produce, followed by a dip that feeds craving. These two proteins are the most studied targets in this field.

CB1 and THC no data here

CB1 is the receptor THC acts on in the brain, and it sits on many of the same reward pathways. None of the studies cited on this page gave THC to people or animals with amphetamine problems, so its effect here is unmeasured.

CB2 and β-caryophyllene in rodents

β-caryophyllene is a terpene found in cannabis, black pepper and cloves, and an FDA-approved food additive. It binds CB2 about 60 times more strongly than CB1 [11].In male rodents it reduced methamphetamine self-administration and drug-seeking, and a CB2-blocking compound, AM630, canceled part of the effect, so other receptors are probably involved too [11]. It has not been tested in people.

Non-cannabis comparisons in mice and a review

N-acetylcysteine, a supplement that rebalances the brain chemical glutamate, was tested in male mice given methamphetamine; it did not significantly reduce the drug’s growing effect over time [13]. Oxytocin, a hormone, reduced drug-taking behavior in animal work, and one early trial in 48 men has been run [5]. Neither is a cannabinoid; both show how early this whole field still is.

CBD, the non-intoxicating cannabinoid, was not studied in any of the papers cited here. Its section below says what is and is not known.

What the research shows, strongest first CBD

What the research shows, from strongest to weakest: no human trial of cannabis for this condition

In short: the one randomized trial here tested an online therapy program, not cannabis. The studies in people describe who uses stimulants and what else they use. The only cannabis compound tested against methamphetamine was given to rodents.

A randomized trial can show that something works. A cohort or survey can show a link. A case series shows that something can happen. An animal study suggests a mechanism. The table puts the work on amphetamine-related disorders on those rungs.

Levels of evidence cited on this page, strongest first
LevelWhat exists hereWhat it can tell you
Randomized trialOne trial of an online CBT program, 160 adults [9]Whether that program works. Nothing about cannabis.
Cohort studiesPeople entering treatment in Australia [14]; methamphetamine use in pregnancy [15]Patterns and links over time, not causes.
Surveys and cross-sectional studiesYoung people in the US [16], teens in Sierra Leone [12], villagers in Thailand [17]How common use is and what goes with it at one moment.
ReviewA narrative review of oxytocin [5]A summary of early work; background only.
Case seriesYoung children who swallowed ADHD stimulants [8]A warning that something happens; no rates.
Animal studiesβ-caryophyllene in rodents [11]; N-acetylcysteine in mice [13]Possible mechanisms. Not what happens in patients.

What kinds of studies is this evidence built on?

How to read it: one row per type of study cited on this page; a longer bar means more studies of that type. Stronger designs come first. Gray bars mark background work, a review and animal studies, which can suggest ideas but cannot show that patients benefit.

  1. Randomized trials1
  2. Cohort studies2
  3. Surveys1
  4. Cross-sectional studies2
  5. Case series1
  6. Narrative review (background)1
  7. Animal studies (background)2

Seven of the ten studies involve people, and none of those seven gave anyone cannabis. The one cannabis compound tested was given to rodents.

Show as a table
Studies cited on this page, by design
DesignStudies
Randomized trials1
Cohort studies2
Surveys1
Cross-sectional studies2
Case series1
Narrative review (background)1
Animal studies (background)2

Browse the studies cited here

One card per paper, newest first, in a sentence or two. Papers that never looked at cannabis are kept and marked, because they describe the condition itself.

2025 · Animal study · 104 male mice [13] Not a cannabis study

N-acetylcysteine and methamphetamine sensitization

The supplement did not significantly blunt the way repeated methamphetamine built up its effect in young mice; only males and one dose pairing were tested [13].

2024 · Cross-sectional study · 1,314 students [12]

Amphetamine use among teens in Sierra Leone

6.1% had ever used amphetamine [12].Those who had used marijuana had much higher odds of having used it too (13.31 times), a link and not a cause [12].

2023 · Cohort study · 9,981 records [14]

People entering treatment in New South Wales

23.5% had used amphetamine-type stimulants in the past 28 days, 8.3% on 13 or more days [14].Frequent users had higher odds of arrest and lower quality of life [14].

2022 · Narrative review [5] Not a cannabis study

Oxytocin for methamphetamine use disorder

Mostly animal research plus one human trial of 48 men; the review also tracks the rise of methamphetamine use disorder [5].

2021 · Animal study, male rodents [11]

β-caryophyllene and methamphetamine-seeking

The cannabis terpene reduced methamphetamine-taking and drug-seeking in rodents, partly through CB2 receptors [11].

2018 · Case series · 5 confirmed cases [8] Not a cannabis study

Young children who swallowed ADHD stimulants

Urine amphetamine levels ranged from 2,067 to 45,751 ng/mL and did not clearly match how sick the children were [8].

2014 · Survey · 229,705 people aged 12 to 34 [16] Not a cannabis study

Nonmedical stimulant use among young Americans

Past-year nonmedical stimulant use was 3.15% among White and 0.9% among Asian-American respondents, with lower odds for Asian-Americans (0.73) [16].

2014 · Randomized trial · 160 adults [9] Not a cannabis study

An online program for stimulant users

No clear change in stimulant use at three months; fewer days out of usual roles [9].

2010 · Cohort study · 191 mothers [15] Not a cannabis study

Methamphetamine use during pregnancy

84.3% used in the first trimester, and use declined as pregnancy went on [15].

2009 · Cross-sectional study · 548 villagers [17]

Methamphetamine in two Karen villages in Thailand

9.9% had used it in the past year: 17.6% of men and 1.7% of women [17].Recent opium, marijuana or heroin use went with far higher odds (19.63) [17].

How to read the numbers What science doesn’t know yet

Two of the studies in people measured cannabis next to amphetamine use. Their numbers are odds ratios: how many times more often something showed up in one group than in another. They describe who uses what together, and they cannot say what caused what.

What went together with amphetamine use in two large studies?

How to read it: each row is one comparison. The dot is the best estimate, the line is the likely range (95% confidence interval), and the vertical line marks no difference. A dot to the right means more often; a hollow dot means about the same.

Among the teens, marijuana went with by far the biggest jump in amphetamine use; among adults already in treatment, how often they used stimulants made almost no difference to how often they used cannabis.

Show as a table
Odds ratios with 95% confidence intervals, from the two studies
ComparisonOdds ratio (95% CI)Study
Lifetime amphetamine use: ever used marijuana13.31 (6.61-28.78)Cross-sectional, 1,314 teens [12]
Lifetime amphetamine use: current alcohol use4.85 (2.61-9.03)Cross-sectional, 1,314 teens [12]
Lifetime amphetamine use: peer support3.19 (1.71-5.96)Cross-sectional, 1,314 teens [12]
Lifetime amphetamine use: planned suicide2.54 (1.02-6.31)Cross-sectional, 1,314 teens [12]
Frequent use: arrest1.74 (1.36-2.24)Cohort, 9,981 clients [14]
Frequent use: days of cannabis use1.01 (1.00-1.02)Cohort, 9,981 clients [14]
Frequent use: overall quality of life0.91 (0.86-0.97)Cohort, 9,981 clients [14]

What is known about CBD Safety and who should avoid cannabis

CBD and stimulant use disorder: what is known and what is not

None of the studies cited here tested CBD in people or animals with an amphetamine problem, so nothing on this page shows that CBD helps with craving, withdrawal or relapse. CBD and THC are different substances: what is said about the intoxicating effects or psychosis risk of THC does not transfer to a CBD-only product, and a finding about CBD would not transfer to THC.

What is known about long-term CBD safety comes mostly from the prescription medicine Epidiolex, approved for rare forms of epilepsy. Its label lists sleepiness, raised liver enzymes and interactions with other medicines handled by the same liver enzymes [18].

State-program products and hemp CBD are not the same thing

What it is

State-program products

THC and CBD products sold to registered patients under state rules.

Hemp CBD and delta-8

Sold in stores and online outside medical programs; delta-8 THC is usually made from hemp CBD by a chemical process.

Tested and labeled

State-program products

Lab-tested, with THC and CBD amounts on the label.

Hemp CBD and delta-8

Testing varies; amounts and contaminants may not match the label.

THC content

State-program products

Stated on the package, from CBD-only to high THC.

Hemp CBD and delta-8

“CBD” items can carry enough THC to cause a positive drug test; delta-8 is itself intoxicating.

Who reviews your health

State-program products

A licensed physician, before the recommendation.

Hemp CBD and delta-8

No one.

For someone in recovery or in a program that tests for THC, an unlabeled “CBD” product is a real risk to a clean test result. The legal side is covered in drug tests and programs.

CBD and your medicines What science doesn’t know yet

Most of what you would want to know has simply not been studied. The authors of the work cited here list these limits themselves.

  • No randomized trial has tested cannabis, THC or CBD as a treatment for amphetamine or methamphetamine use disorder.
  • The animal work used male rodents only, and the N-acetylcysteine study used a single dose pairing [11][13].
  • The only human trial in the oxytocin review enrolled men who have sex with men, so it says little about anyone else [5].
  • The surveys capture one moment and rely on people’s own reports, which can miss or blur heavy use [12][16].
  • The Thai village study had only 54 methamphetamine users, too few for firm conclusions [17].
  • No study here looked at women, at teenagers in the US, or at people with psychosis using both drugs.
  • Methamphetamine use in pregnancy has been described, with 84.3% of 191 mothers using it in the first trimester, but cannabis was not the subject [15].

Three questions for any headline about cannabis and stimulants

  1. People or rodents? The promising results so far are in rats and mice.
  2. Cannabis or a single molecule? β-caryophyllene is one terpene, not a cannabis product.
  3. A link or a test? A survey that finds two habits together has not tested a treatment.

If an article skips these, bring it to your appointment as a question rather than an answer.

What is known about the risks

Is cannabis safe with an amphetamine use disorder? Second dependence, psychosis and the heart

No study has followed people with this disorder who use medical cannabis, so there is no measured safety record for this group. The risks below come from what is known about THC and stimulants in general and from the precautions the study authors give.

A second dependence

Cannabis use disorder is real, and a history of one substance problem raises the odds of another. Daily use and high-THC products carry the most risk.

Psychosis from two directions

Stimulants can cause paranoia and hallucinations, and high-THC cannabis can trigger or worsen psychosis. Together the risk adds up.

Heart rate and blood pressure

Amphetamines raise both, and THC speeds the heart too. People with heart disease or high blood pressure have the least margin.

Alcohol creeping up

When methamphetamine use falls, alcohol use can rise in its place, and study authors advise clinicians to watch for it. The same applies to cannabis.

Sleep and mood in withdrawal

THC can make it easier to fall asleep yet leave sleep less restful, and stopping it brings its own irritability and poor sleep.

Driving

THC slows reaction time, and the crash after stimulants brings deep fatigue. Neither mixes with a car.

Who should not use cannabis, or only with close medical supervision

  • Anyone who has had psychosis, from stimulants or otherwise, or who has a parent or sibling with schizophrenia.
  • People with schizophrenia, schizoaffective disorder or bipolar disorder, who were left out of the studies cited here.
  • Anyone pregnant or breastfeeding.
  • People with heart disease, an irregular heartbeat or uncontrolled high blood pressure.
  • Anyone under 21.
  • Anyone in a crisis, in the first days of withdrawal or having thoughts of suicide.
  • Anyone who has had cannabis use disorder before.

Do not stop or reduce a prescribed medicine on your own to make room for cannabis; that change belongs to the prescriber.

Check your medicine list Cannabis and mental health

Cannabis with Adderall, Vyvanse, bupropion, naltrexone, mirtazapine and antipsychotics

The studies on this page did not test any of these combinations. Each entry below is general pharmacology, marked as such, for your physician and pharmacist to check against your own list.

What is on your medicine list?

Have the pharmacy printout or the bottles at hand and tap everything you take; the matching entries open below.

Adderall, Vyvanse and other prescribed stimulants general pharmacology

Both raise heart rate, and THC can add anxiety, a racing feeling or poor sleep on top of the stimulant. Some people use cannabis to come down in the evening, which can blur whether the dose or timing of the stimulant needs changing. Tell the prescriber about any cannabis use.

Bupropion and naltrexone general pharmacology

Bupropion lowers the seizure threshold and can raise anxiety and blood pressure; CBD may change how the liver handles some medicines, according to the Epidiolex label [18]. Naltrexone itself has no well-known cannabis interaction, but both drugs are in your plan for a reason, so keep the prescriber informed.

Mirtazapine, trazodone and sleep medicines general pharmacology

Sedation adds up. THC on top of mirtazapine or a sleeping pill can mean heavy grogginess the next morning, falls and unsafe driving. Both mirtazapine and THC can also raise appetite.

Antipsychotics general pharmacology

THC can work against the reason the antipsychotic was prescribed. Smoke from any burned plant speeds the breakdown of clozapine and olanzapine, so starting or stopping smoking can shift their blood levels; the prescriber may need to check them.

SSRIs, SNRIs and other antidepressants general pharmacology

CBD can slow liver enzymes that clear some antidepressants, such as citalopram, which may raise their levels [18]. THC can also mask or worsen low mood, which makes it harder to judge whether the antidepressant is working.

Benzodiazepines such as Xanax general pharmacology

People sometimes take these to soften a stimulant crash. Adding THC deepens sedation and slows reactions. More on this pairing: mixing marijuana and Xanax.

Alcohol general pharmacology

Alcohol and THC together impair more than either alone, and alcohol use often rises when stimulant use falls. If you notice that pattern, raise it with your physician early.

Questions to ask about your medicine list

  • Would THC or CBD change the level or effect of anything I take?
  • Which of my medicines already make me drowsy, anxious or raise my heart rate?
  • Is there a reason in my history, such as psychosis or a heart problem, to avoid cannabis completely?
  • If I go ahead, what should we check, and when?

What each form of cannabis avoids and keeps Preparing for the appointment

Smoked, vaped, eaten or under the tongue: what each form avoids and what stays

Medical cannabis is smoked, vaped, eaten, swallowed as capsules, dropped under the tongue, rubbed on skin or worn as a patch. No study here compares forms for people with stimulant problems, so none is ranked as safer. What can be said is what each form avoids and what it keeps. Choosing a form is a decision for you and a physician, not for this page.

Which form are you asking about?

The card that applies to every form stays open; picking a form adds what is specific to it.

Smoking: joints, blunts, pipes, bongs

Burning plant matter puts smoke and carbon monoxide in the lungs and makes the heart work harder, on top of what a stimulant already does. For someone who used to smoke methamphetamine, a pipe and a lighter can work as a cue for craving.

Vaping and dabbing

No burning, yet hot aerosol still reaches the airways, and the hand-to-mouth ritual is close to that of smoking stimulants. Concentrates used for dabbing are strong enough that a small amount is a large THC dose, which matters most for psychosis risk.

Edibles, drinks and capsules

No smoke and no inhaling ritual, but the effect starts late and lasts for hours, and the liver handles the dose first. A second helping taken because “nothing happened yet” is a common route to too much THC, with panic or paranoia.

Tinctures, oils and mouth sprays

Held under the tongue, counted in drops, and easier to log. Part of each dose is still swallowed, so interactions with your medicines stay the same.

Creams, balms and patches

Creams and balms act mostly where they are applied. Transdermal patches deliver cannabinoids into the blood, so drowsiness and interactions are the same questions as for anything swallowed.

Prescription cannabinoids: dronabinol, nabilone, Epidiolex

FDA-approved medicines filled at a pharmacy with a fixed dose, not products bought with a medical card. None is approved for a stimulant use disorder; their labels list side effects and interactions [18].

True of every form

  • THC reaches the brain whichever way it is taken, with the same risks for dependence and psychosis.
  • THC and CBD can interact with medicines once they are in the blood.
  • THC causes drowsiness and slowed reactions; do not drive after use.
  • Only tested, labeled products tell you how much you are taking.
All forms as a table
What each form avoids and what it keeps; forms that are not inhaled have their own rows
FormWhat it avoidsWhat it keeps
SmokingA delayed onsetSmoke, heart strain, a ritual close to stimulant smoking, every effect of THC
Vaping and dabbingBurning plant matterHot aerosol, a similar ritual, very strong concentrates
Edibles and capsulesSmoke and the inhaling ritualLate onset, long effect, the second-helping trap, interactions
Tinctures and spraysSmoke and aerosolPart of the dose swallowed, interactions, drowsiness
Creams and balmsMost effects elsewhere in the bodySkin reactions
Transdermal patchesSmoke, aerosol, swallowingCannabinoids in the blood, interactions, drowsiness
Prescription cannabinoidsUnknown product contentLabel side effects and interactions; not approved for this disorder

Drug tests, programs and the law

Does amphetamine use disorder qualify for a medical card?

By name, almost never. State programs list conditions such as chronic pain, PTSD or cancer, and stimulant use disorder is not a typical entry. What matters at an evaluation is a listed condition in your records, or a state rule that lets the physician certify a serious condition not on the list. The list in force on the day of your appointment is the one that counts.

Rarely listed

The use disorder itself

Expect the physician to look at what you live with now, not at the stimulant diagnosis.

Listed diagnosis

A condition in your records

Anxiety, PTSD, insomnia or chronic pain appear on many state lists when a clinician has documented them.

Physician judgment

States with an open clause

Some programs allow a physician to certify a condition not on the list. Your state’s rules say whether yours does.

What else is in your medical records?

Programs count diagnoses written down by a clinician, not symptoms alone. Pick what applies.

Anxiety. Often present before stimulant use and often worse during withdrawal. Several states list it; the research is on anxiety and medical cannabis. High-THC products can also make anxiety worse.

PTSD. One of the most widely listed conditions, and common among people with stimulant problems. See PTSD and medical cannabis.

Insomnia. Broken sleep is one of the longest-lasting parts of recovery. See insomnia and medical cannabis.

Chronic pain. Listed in some form by most programs. Bring the diagnosis and what you have already tried; see chronic pain and medical cannabis.

Depression. Rarely listed on its own, and THC can deepen low mood in some people. The evidence is on depression and medical cannabis.

None of these. Whether you can be certified then depends on your state’s wording and the physician’s judgment. Check your state in laws by state, and see how cards work without a listed condition.

Medical cannabis by state: what a card changes

Legal status, possession limits, taxes and whether patients may grow at home all differ by state and change often, so they are kept current on each state’s page in medical marijuana laws by state. The general picture:

Who looks at your health first

With a medical card

A licensed physician reviews your stimulant history, psychiatric history and medicines.

Buying without one

No one.

Taxes

With a medical card

In several states, patients skip part of the cannabis tax.

Buying without one

The full tax, where adult sales are legal at all.

Possession limits and home growing

With a medical card

Often higher limits, and in some states the right to grow a few plants.

Buying without one

The adult limit, or no legal option.

What you know about the product

With a medical card

Tested products with THC and CBD on the label.

Buying without one

In states without adult sales, only untested sources.

How the tax side compares is set out in medical and adult-use cannabis taxes.

If you are reading this for someone you love

Watching someone you love on stimulants is frightening, and the instinct to confront them head-on usually pushes them away. Approaches that train families to stay calm, reward sober time and invite treatment at the right moment work better than ultimatums, and SAMHSA can point you to them.

Starting the conversation

  • Pick a calm, sober moment, not the middle of a crash.
  • Describe what you have seen and how it affects you, without labels such as “addict.”
  • Offer one concrete next step: a call to the helpline, a doctor’s visit, a program.
  • Look after your own sleep and support too.

Staying safe

  • Street stimulants and counterfeit pills can contain fentanyl. Keep naloxone at home and learn how to use it [21].
  • Know the warning signs of overheating, chest pain and psychosis.
  • If someone talks about suicide, call or text 988 together.
  • Lock away any prescribed stimulants in the house.

The SAMHSA National Helpline at 1-800-662-4357 takes calls from family members as well as from people who use [2].

Warning signs that need help now How treatment works

How to talk to a physician about cannabis and amphetamine

Say plainly what you use, how much and how often, including stimulants that were not prescribed to you. Physicians need it to keep you safe, it does not decide whether you get care, and they have heard it many times before.

What to bring

Tap each item when it is ready.

Questions worth asking

  • Given my stimulant history, is my risk of cannabis dependence or psychosis higher than average?
  • Would THC or CBD affect any of my current medicines?
  • Is there something other than cannabis we should try first for this symptom?
  • If we go ahead, what warning signs should make me stop and call you?

A physician may decide that cannabis is not right for you, and that is a normal outcome of a careful evaluation, not a failure.

Getting a medical card online: steps, renewal, price and what happens after you pay

The evaluation happens from home, with a physician licensed in your state, and it starts with a short form. The full process is described on the medical card page.

  1. About 5 minutes

    Complete the form

    Your state, your diagnoses, current medicines and an honest note on stimulant and cannabis use.

  2. About 15 minutes

    The appointment

    One on one with the physician, all online. You agree on the time with them; keep an hour free around it in case they run late.

  3. In as little as 15 minutes after the appointment, depending on your state

    The recommendation

    When the physician approves it, the signed document is waiting in your account.

  4. Timing set by the state

    Registration, if required

    Some states also ask you to register with their program, which then issues the card on its own timeline.

4.6out of 5 on Google

Across 250 reviews from patients in the states where we are licensed. We do not sort them by score and do not hide the low ones.

  • 150,000+patients evaluated – everyone who has been through an appointment with us, in every state where we are licensed
  • Since 2017doing only this: online evaluations for medical cannabis programs, and nothing else on the side

You see the evaluation fee for your state before you pay, with no extra charge added afterward; a state registration fee, where one exists, is paid to the state. Approval is never promised in advance, and what happens to the fee if the physician declines is answered in the medical card FAQ. Reduced prices are available for veterans and people on a low income. You can move an appointment on your appointments page, and renewing later starts from the same account.

Chest pain, seizures, overheating or thoughts of suicide need 911 or 988, not an online appointment.

Amphetamine use disorder and cannabis: frequently asked questions

What is amphetamine-type use disorder?

It is the DSM-5-TR name for a problematic pattern of using amphetamine, methamphetamine or a related stimulant, diagnosed when at least 2 of 11 criteria apply within 12 months and graded mild, moderate or severe [3]. See the 11 criteria.

What does “unspecified amphetamine-related disorder” mean?

It is the label, code F15.99, for a stimulant-caused problem that does not fit a named diagnosis, or when there is not yet enough information to choose one [4].

What is the ICD-10 code for severe amphetamine use disorder?

F15.20, the same code as for moderate; the severity is written next to it. Mild is F15.10 [4]. The code table lists intoxication, withdrawal and psychosis codes.

Are amphetamines narcotics?

No, not in the medical sense, which means opioids. Amphetamines are stimulants and, under federal law, Schedule II controlled substances [6].

Does vitamin C affect amphetamines?

Acidic foods and drinks, including vitamin C and fruit juice, can lower how much of an oral amphetamine dose is absorbed and speed its removal in urine. If you take a prescribed stimulant, ask your pharmacist about timing rather than using vitamin C to change its effect.

What are the long-term effects of amphetamine misuse?

Weight loss, dental damage, heart strain, sleep problems, anxiety, depression, memory trouble and psychosis, mostly with high doses, binges and methamphetamine [7]. See effects on the body and mind.

How is amphetamine use disorder treated?

With behavioral therapy such as CBT and contingency management, treatment of other conditions, and support over time. No medicine is FDA-approved for it, though some are being studied. Treatment in detail.

Can CBD help with amphetamine use disorder?

That is unknown. None of the studies cited here tested CBD for it. The one cannabis compound tested against methamphetamine was a terpene, β-caryophyllene, in rodents [11].

Is delta-8 THC the same as medical cannabis?

No. Delta-8 is usually made from hemp CBD by a chemical process and sold outside state medical programs, without the same testing. It is intoxicating and can cause a positive drug test.

Can I use cannabis while taking Adderall?

Only after talking with the prescriber. Both raise heart rate, and THC can add anxiety and disturb sleep. See interactions.

Will a medical card affect my treatment program or probation?

It can. Many programs and courts test for THC and count it as use whatever your card says. Ask before you start; the legal section has the details.

Does a medical card show up on a background check?

A card is not a criminal record, and state registries are confidential under state law. It does matter for federal firearms purchases, where the form asks about marijuana use. See firearms.

Where do patients buy cannabis with a card?

At licensed dispensaries in the state program. In some states the signed recommendation is enough; in others you register first and wait for the card. Your state’s page in laws by state and the medical card FAQ give the next step.

Does amphetamine use disorder qualify for a medical marijuana card?

Rarely by name. A listed condition in your records, such as anxiety, PTSD, insomnia or chronic pain, or a state rule allowing physician judgment, is the usual route. See qualifying.

More medical card questions

This page cites a selection of studies. Our research library holds every study we track on cannabis and amphetamine-related disorders, from laboratory work to clinical trials, and lets you filter them by cannabinoid, study type and year.

studies
46
in people
21
clinical trials
3

See the studies on amphetamine-related disorders

Talk your situation through with a licensed physician

What cannabis cannot do here: treat an amphetamine use disorder or replace therapy and support.

What a physician can do: look at your history, your medicines and your state’s rules, and tell you whether medical cannabis makes sense for the symptoms you live with now. The appointment is private and online, with no waiting room.

You see the fee for your state before paying. In a crisis, call 911, call or text 988, or call SAMHSA at 1-800-662-4357.

Share your experience

Leave an anonymous messageTell us what this page failed to answer, or where we got something wrong. It goes to the team, not onto the page, and no account or email is needed.
Share your storyA longer account of living with this condition, written for the people who arrive at this page next. Published with your first name, or anonymously if you ask.
Write a public commentAsk a question, correct us, or answer somebody else’s question at the foot of this page. Comments are public once they clear moderation.Add a comment

    💬

    How else can we help you?

    Tell us what you’d like to see, learn, or get from us next.

    🕶️
    100% anonymous — share what’s on your mind
    We will only use it if we need to follow up on your message.

      💬

      Share Your Story with the Dr. Weedy Community

      Your positive, negative, or neutral experience can really help others. Feel free to share it in a few clear, short sentences.

      🕶️
      Your contact details are encrypted and will never be shared publicly

      References

      21 sources
      1. 1. 988 Suicide and Crisis Lifeline. 988 Lifeline. 2025.
      2. 2. Substance Abuse and Mental Health Services Administration. SAMHSA’s National Helpline. 2025.
      3. 3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). 2022.
      4. 4. Centers for Medicare & Medicaid Services. ICD-10-CM code set. 2025.
      5. 5. Edinoff AN, Thompson E, Merriman CE, et al. Oxytocin, a Novel Treatment for Methamphetamine Use Disorder. Neurol Int · 2022 · narrative_review DOI: 10.3390/neurolint14010015 PMID: 35225885
      6. 6. Drug Enforcement Administration. Drug Fact Sheet: Amphetamines. 2022.
      7. 7. National Institute on Drug Abuse. Methamphetamine DrugFacts. 2024.
      8. 8. Wood KE, McCarthy PJ, Krasowski MD A case series involving young children presenting with accidental ingestion of amphetamine based stimulants. Toxicol Rep · 2018 · case_report DOI: 10.1016/j.toxrep.2018.11.001 PMID: 30510906
      9. 9. Tait RJ, McKetin R, Kay-Lambkin F, et al. A Web-Based Intervention for Users of Amphetamine-Type Stimulants: 3-Month Outcomes of a Randomized Controlled Trial. JMIR Ment Health · 2014 · rct DOI: 10.2196/mental.3278 PMID: 26543901
      10. 10. Substance Abuse and Mental Health Services Administration. FindTreatment.gov. 2025.
      11. 11. He XH, Galaj E, Bi GH, et al. β-caryophyllene, an FDA-Approved Food Additive, Inhibits Methamphetamine-Taking and Methamphetamine-Seeking Behaviors Possibly via CB2 and Non-CB2 Receptor Mechanisms. Front Pharmacol · 2021 · preclinical DOI: 10.3389/fphar.2021.722476 PMID: 34566647
      12. 12. Osborne A, Aboagye RG, Olorunsaiye CZ, et al. Prevalence and predictors of lifetime amphetamine use among in-school adolescents in Sierra Leone. BMJ Open · 2024 · cross_sectional DOI: 10.1136/bmjopen-2023-080225 PMID: 38471692
      13. 13. Máchalová A, Landa L, Máchal J, et al. The Effect of N-Acetylcysteine on Behavioral Sensitization to Methamphetamine in Mice. Physiol Res · 2025 · preclinical DOI: 10.33549/physiolres.935471 PMID: 40432447
      14. 14. Black E, Mammen K, Deacon RM, et al. Health and social characteristics of clients reporting amphetamine type substance use at entry to public alcohol and other drug services in New South Wales, Australia, 2016-2019. Drug Alcohol Rev · 2023 · cohort DOI: 10.1111/dar.13588 PMID: 36524444
      15. 15. Della Grotta S, LaGasse LL, Arria AM, et al. Patterns of methamphetamine use during pregnancy: results from the Infant Development, Environment, and Lifestyle (IDEAL) Study. Matern Child Health J · 2010 · cohort DOI: 10.1007/s10995-009-0491-0 PMID: 19565330
      16. 16. Wu LT, Swartz MS, Brady KT, et al. Nonmedical stimulant use among young Asian-Americans, Native Hawaiians/Pacific Islanders, and mixed-race individuals aged 12-34 years in the United States. J Psychiatr Res · 2014 · survey DOI: 10.1016/j.jpsychires.2014.09.004 PMID: 25263275
      17. 17. Kobori E, Visrutaratna S, Maeda Y, et al. Methamphetamine use and correlates in two villages of the highland ethnic Karen minority in northern Thailand: a cross sectional study. BMC Int Health Hum Rights · 2009 · cross_sectional DOI: 10.1186/1472-698X-9-11 PMID: 19445678
      18. 18. U.S. Food and Drug Administration. Epidiolex (cannabidiol) prescribing information. 2018.
      19. 19. Bureau of Alcohol, Tobacco, Firearms and Explosives. ATF Form 4473, Firearms Transaction Record. 2023.
      20. 20. Electronic Code of Federal Regulations. 42 CFR Part 2, Confidentiality of Substance Use Disorder Patient Records. 2024.
      21. 21. Centers for Disease Control and Prevention. Lifesaving Naloxone. 2024.
      0 Comments
      Security check required

      Our security system needs to verify your connection. Please reload the page and complete the quick verification — your details are safe and nothing was lost.